Free Membership
Newsletter
Help
Subscribe
Sign In
Search
July 3, 2022
All times are Vienna time
Search
Subscribe
Sign In
Countries:
Africa »
Algeria Angola Benin Botswana Burundi Côte d'Ivoire Ethiopia Ghana Guinea Kenya Lesotho Liberia Libya Mali Mauritius Morocco Mozambique Namibia Niger Nigeria Rwanda South Africa Sudan Tanzania The Congo Togo Tunisia Uganda Zambia Zimbabwe
Asia-Pacific »
Afghanistan Australia Bangladesh Cambodia China Hong Kong SAR India Indonesia Japan Laos Malaysia Mongolia Myanmar Nepal New Zealand North Korea (DPRK) Pakistan Philippines Singapore South Korea Sri Lanka Taiwan Thailand Vietnam
Central- & Eastern Europe »
Albania Bosnia & Herzegovina Bulgaria Croatia Czech Rep. Estonia Georgia Hungary Kosovo Latvia Lithuania North Macedonia Montenegro Poland Romania Serbia Slovakia Slovenia Ukraine Western Balkans
Middle East »
Egypt Iran Iraq Israel Jordan Kuwait Lebanon Oman Palestinian Territories Qatar Saudi Arabia Syria Turkey United Arab Emirates Yemen
Russia & CIS »
Russia Armenia Azerbaijan Belarus Kazakhstan Kyrgyzstan Moldova Turkmenistan Uzbekistan
The Americas »
Argentina Bolivia Brazil Canada Central America Chile Colombia Cuba Ecuador Mexico Panama Paraguay Peru The Caribbean Uruguay Venezuela
United States
Western Europe »
Belgium Cyprus Denmark Finland France Germany Greece Iceland Ireland Italy Liechtenstein Luxembourg Malta Monaco Norway Portugal Scotland Spain Sweden Switzerland The Netherlands United Kingdom Vatican City
Business:
Economy
Economic Policies
Investing in Austria
Securities
Earnings
Foreign Trade
Deals
Legal Issues
More Business & Economics+
Politics:
Domestic
Brussels
International
Diplomacy
Companies:
Professional Services »
Banks Financial Services Real Estate Insurance Other Services
Energy »
Oil & Gas Utilities Renewables Mining
Industrials »
Construction Automotive Industrial Goods Basic Resources Chemicals Other Industrials
Transport »
Airlines & Airports Shipping Rail Road
Retail & Consumer
Health Care
Technology
Telecoms
Media
Tourism
Other
Organizations:
Diplomatic Missions
International Organizations
Other
People:
Executives
Politicians
Diplomats
Entrepreneurs
Other
Lifestyle & Travel:
Culture
Travel
Personal Real Estate
Health
Food & Drink
Luxury Goods
More+
More+:
Events
Photo Galleries
Videos
Classifieds
Work & Careers
More+
Home
Countries
Business
Politics
Diplomacy
Companies
Organizations
People
Lifestyle & Travel
More+
Africa
Algeria
Angola
Benin
Botswana
Burundi
Côte d'Ivoire
Ethiopia
Ghana
Guinea
Kenya
Lesotho
Liberia
Libya
Mali
Mauritius
Morocco
Mozambique
Namibia
Niger
Nigeria
Rwanda
South Africa
Sudan
Tanzania
The Congo
Togo
Tunisia
Uganda
Zambia
Zimbabwe
Asia-Pacific
Afghanistan
Australia
Bangladesh
Cambodia
China
Hong Kong SAR
India
Indonesia
Japan
Laos
Malaysia
Mongolia
Myanmar
Nepal
New Zealand
North Korea (DPRK)
Pakistan
Philippines
Singapore
South Korea
Sri Lanka
Taiwan
Thailand
Vietnam
Central- & Eastern Europe
Albania
Bosnia & Herzegovina
Bulgaria
Croatia
Czech Rep.
Estonia
Georgia
Hungary
Kosovo
Latvia
Lithuania
North Macedonia
Montenegro
Poland
Romania
Serbia
Slovakia
Slovenia
Ukraine
Western Balkans
Middle East
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Oman
Palestinian Territories
Qatar
Saudi Arabia
Syria
Turkey
United Arab Emirates
Yemen
Russia & CIS
Russia
Armenia
Azerbaijan
Belarus
Kazakhstan
Kyrgyzstan
Moldova
Turkmenistan
Uzbekistan
The Americas
Argentina
Bolivia
Brazil
Canada
Central America
Chile
Colombia
Cuba
Ecuador
Mexico
Panama
Paraguay
Peru
The Caribbean
Uruguay
Venezuela
United States
Western Europe
Belgium
Cyprus
Denmark
Finland
France
Germany
Greece
Iceland
Ireland
Italy
Liechtenstein
Luxembourg
Malta
Monaco
Norway
Portugal
Scotland
Spain
Sweden
Switzerland
The Netherlands
United Kingdom
Vatican City
Economy
Economic Policies
Investing in Austria
Securities
Earnings
Foreign Trade
Deals
Legal Issues
More Business & Economics+
Domestic
Brussels
International
Professional Services
Banks
Financial Services
Real Estate
Insurance
Other Services
Energy
Oil & Gas
Utilities
Renewables
Mining
Industrials
Construction
Automotive
Industrial Goods
Basic Resources
Chemicals
Other Industrials
Transport
Airlines & Airports
Shipping
Rail
Road
Retail & Consumer
Health Care
Technology
Telecoms
Media
Tourism
Other
Diplomatic Missions
International Organizations
Other
Executives
Politicians
Diplomats
Entrepreneurs
Other
Culture
Travel
Personal Real Estate
Health
Food & Drink
Luxury Goods
More+
Events
Photo Galleries
Videos
Classifieds
Work & Careers
More+
Latest News
Ukrainian War
Covid in Austria
USA in Vienna
UK in Vienna
Russia in Vienna
China in Vienna
Iran in Vienna
UN
OSCE
IAEA
OPEC
Sponsored Content
Tweet
Share

Third Covid-19 Vaccine: Only Approval for 18 to 64 Years Olds in Austria

Lifestyle & Travel › Health ♦ Published: February 1, 2021; 20:45 ♦ (Vindobona)
Sponsored Content

The European Medicines Agency (EMA) has approved a third Covid-19 vaccine - produced by Astra Zeneca. However, Austria's National Immunization Panel has recommended the use of the newest of the three vaccines only for the age groups below 65 due to a lack of sufficient data for older generations.

The third Covid-19 vaccine, produced by AstraZeneca, will soon be used in Austria. However, only people up to the age of 65 will receive the newly approved vaccine. / Picture: © Bundeskanzleramt (BKA) / Dragan Tatic

After the approval of the third Covid-19 vaccine by the European Medicines Agency (EMA) on January 29, 2021, Austria's 18 members of the National Immunization Panel at the Department of Health and Human Services has unanimously recommend the use of Astra-Zeneca vaccine only in the 18- to 64-year-old age group.

"There are sufficient good safety and effectiveness data for this age group to recommend the vaccine as having good efficacy against symptomatic infection and severe morbidity (hospitalization, intensification, death) for 18- to 64-year-olds," according to the preamble to the recommendation, which was released on January 31, 2021.

For people over the age of 65, the mRNA vaccines (from BioNTech/Pfizer and Moderna) should be preferred.

Sponsored Content

However, "In the event of logistical problems in vaccine use with the mRNA vaccines, there is nothing to prevent use of the Astra-Zeneca vaccine in persons 65 plus," the recommendation states.

In the group of 65 years old and older, safety and immunogenicity data are comparable to those in 18-64 year olds, it said.

"Due to the small group size and the low number of cases of disease that have occurred, it is not possible at this time to make a reliable statement on efficacy for this age group," the expert panel states.

The panel concludes that "until further data are available in this age group, the preferred use of mRNA vaccines in persons 65 plus and high-risk patients is recommended according to the prioritization list."

The vaccination panel assumes, however, that when further data are available, another recommendation can be made.

Health Minister Rudolf Anschober and Chancellor Sebastian Kurz reacted to the recommendation of the vaccination panel with a joint statement, saying:

"With the approval by the EMA and the decision of the National Vaccination Panel, we now have clear guidance for the vaccine from Astra Zeneca in our hands and can start very quickly - if possible from February 7 - with the third approved vaccine in Austria."

The responsible committee of the European Medicines Agency EMA in Amsterdam issued a recommendation for approval without age limit.

According to the EU's Medical experts, the number of symptomatic diseases of Covid-19 n the age group of 18 to 55 years could be reduced by 59.5 percent.

Although the EMA also points out that there is not yet enough data for people over 55 "to make a firm statement about how well the vaccine works in this age group," the EMA says that some protection can be expected.

Sponsored Content
Sponsored Content

Italy, for example, recommends use only up to the age of 55, while Germany recommends use up to ages of 64.

Copyright © Vindobona. You may share using our article tools. Please don't cut articles from Vindobona and redistribute by email or post to the web.
Sponsored Content
Fast News Search
Related News
Covid-19 Vaccine: Austria Awaits Approval for AstraZeneca (January 25, 2021)
EMA Approves Second Covid-19 Vaccine: Austria Receives 890,000 Doses (January 7, 2021)
EMA Approves Covid-19 Vaccine (December 21, 2020)
Read More
Vaccines, Sebastian Kurz, Rudolf Anschober, EMA European Medicines Agency, COVID-19, Coronavirus, AstraZeneca
Featured
See latest Vindobona Newsletter
Sign up now for full site access and to read a limited amount of free premium articles per month:
Sign Up
×
Sponsored Content
©1995-2022 Vindobona
Contact
Help
Imprint
Press
Careers
Partners
Terms & Conditions
Site Security
Privacy
Sitemap
Advertise
About Us